---
figid: PMC6701981__EMS84021-f001
figlink: /pmc/articles/PMC6701981/figure/F1/
number: Figure 1
caption: 'Several classes of drugs are tested in clinical trials aimed at either inhibiting
  catabolic signaling (drug name red) and thereby reducing protein degradation (orange),
  or stimulating anabolic pathways (drug name green) and thereby increasing protein
  synthesis (blue). Activation via IGF-1, but also other upstream signals such as
  GH, androgens or β2-agonist, stimulate the PI3K – Akt – mTOR pathway and, as a consequence,
  protein synthesis is increased. In addition, Akt suppresses protein degradation
  by phosphorylating FoxO and thereby reducing its transcriptional activity. Several
  catabolic pathways do not only contribute to muscle atrophy by increasing the expression
  of E3 ligases MAFbx and MuRF1 via the transcription factors FoxO, TFEB or NF-κB,
  which all stimulate protein degradation, but also by inhibiting PI3K – Akt signaling
  and thereby reduce protein synthesis. MSTN is a major negative regulator of muscle
  mass by inhibiting Akt signaling. The multi-factorial nature of secondary muscle
  wasting and the different signaling pathways involved in muscle atrophy aggravates
  the development of effective drugs. Abbreviations not mentioned in the text: T =
  testosterone; GC = glucocorticoid'
pmcid: PMC6701981
papertitle: 'Muscle Wasting Diseases: Novel Targets and Treatments.'
reftext: Regula Furrer, et al. Annu Rev Pharmacol Toxicol. 2019 Jan 6;59:315-339.
pmc_ranked_result_index: '11066'
pathway_score: 0.9361826
filename: EMS84021-f001.jpg
figtitle: 'Muscle Wasting Diseases: Novel Targets and Treatments'
year: '2019'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6701981__EMS84021-f001.html
  '@type': Dataset
  description: 'Several classes of drugs are tested in clinical trials aimed at either
    inhibiting catabolic signaling (drug name red) and thereby reducing protein degradation
    (orange), or stimulating anabolic pathways (drug name green) and thereby increasing
    protein synthesis (blue). Activation via IGF-1, but also other upstream signals
    such as GH, androgens or β2-agonist, stimulate the PI3K – Akt – mTOR pathway and,
    as a consequence, protein synthesis is increased. In addition, Akt suppresses
    protein degradation by phosphorylating FoxO and thereby reducing its transcriptional
    activity. Several catabolic pathways do not only contribute to muscle atrophy
    by increasing the expression of E3 ligases MAFbx and MuRF1 via the transcription
    factors FoxO, TFEB or NF-κB, which all stimulate protein degradation, but also
    by inhibiting PI3K – Akt signaling and thereby reduce protein synthesis. MSTN
    is a major negative regulator of muscle mass by inhibiting Akt signaling. The
    multi-factorial nature of secondary muscle wasting and the different signaling
    pathways involved in muscle atrophy aggravates the development of effective drugs.
    Abbreviations not mentioned in the text: T = testosterone; GC = glucocorticoid'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CREB3L1
  - CREB3L3
  - AKT2
  - CREB3L2
  - AR
  - ARID4B
  - ACVR1B
  - TGFBR1
  - CREB1
  - ATF2
  - BCAT2
  - CREB3
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PRKACA
  - PRKACB
  - CREB5
  - TNFRSF12A
  - FOXO6
  - FOXO1
  - FOXO3
  - FOXO4
  - CREB3L4
  - ATF1
  - STAT3
  - TFEB
  - TNFRSF1A
  - IL1A
  - IL1B
  - IL1R1
  - IL6
  - IRS1
  - JAK1
  - JAK2
  - JAK3
  - CREM
  - PIK3CB
  - EIF4EBP1
  - AKT3
  - AKT1
  - TRIM63
  - NFKB1
  - PDE4A
  - PDE4B
  - PDE4C
  - PDE4D
  - PIK3R6
  - PIK3R5
  - PIK3R4
  - PIK3CA
  - GHR
  - GHRL
  - IGF1
  - IGF1R
  - PRKAR1B
  - PRKAR2A
  - PRKACG
  - PRKAR1A
  - SMAD2
  - PRKAR2B
  - RPS6KB1
  - MSTN
  - TYK2
  - KLF15
  - FBXO32
  - SOCS3
  - SMAD3
  - SUN11031
  - Anamorelin
  - Macimorelin
  - Celecoxib
  - Fosinopril
  - Ruxolitinib
  - Mk-0773
  - Losartan
  - Thalidomide
  - MSTN
  - BIIB023
  - ACE-083
  - Ly2495655
  - REGN1033
  - Cancer
genes:
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L1
  entrez: '90993'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L3
  entrez: '84699'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L2
  entrez: '64764'
- word: AR
  symbol: AR
  source: hgnc_symbol
  hgnc_symbol: AR
  entrez: '367'
- word: BCAA
  symbol: BCAA
  source: hgnc_alias_symbol
  hgnc_symbol: ARID4B
  entrez: '51742'
- word: ALK4/5
  symbol: ALK4
  source: hgnc_alias_symbol
  hgnc_symbol: ACVR1B
  entrez: '91'
- word: ALK4/5
  symbol: ALK-5
  source: hgnc_alias_symbol
  hgnc_symbol: TGFBR1
  entrez: '7046'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB1
  entrez: '1385'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF2
  entrez: '1386'
- word: BCAT2
  symbol: BCAT2
  source: hgnc_symbol
  hgnc_symbol: BCAT2
  entrez: '587'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3
  entrez: '10488'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB5
  entrez: '9586'
- word: Fn14
  symbol: FN14
  source: hgnc_alias_symbol
  hgnc_symbol: TNFRSF12A
  entrez: '51330'
- word: FoxO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO6
  entrez: '100132074'
- word: FoxO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO1
  entrez: '2308'
- word: FoxO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO3
  entrez: '2309'
- word: FoxO
  symbol: FOXO
  source: bioentities_symbol
  hgnc_symbol: FOXO4
  entrez: '4303'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L4
  entrez: '148327'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF1
  entrez: '466'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: TFEB
  symbol: TFEB
  source: hgnc_symbol
  hgnc_symbol: TFEB
  entrez: '7942'
- word: TNFR
  symbol: TNF-R
  source: hgnc_alias_symbol
  hgnc_symbol: TNFRSF1A
  entrez: '7132'
- word: IL.1
  symbol: IL1
  source: bioentities_symbol
  hgnc_symbol: IL1A
  entrez: '3552'
- word: IL.1
  symbol: IL1
  source: bioentities_symbol
  hgnc_symbol: IL1B
  entrez: '3553'
- word: IL-1R
  symbol: IL1R
  source: hgnc_prev_symbol
  hgnc_symbol: IL1R1
  entrez: '3554'
- word: IL-6
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: IRS-1
  symbol: IRS1
  source: hgnc_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREM
  entrez: '1390'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: 4E-BP1
  symbol: 4E-BP1
  source: hgnc_alias_symbol
  hgnc_symbol: EIF4EBP1
  entrez: '1978'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: MURF1
  symbol: MURF-1
  source: hgnc_alias_symbol
  hgnc_symbol: TRIM63
  entrez: '84676'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: PDE4
  symbol: PDE4
  source: bioentities_symbol
  hgnc_symbol: PDE4A
  entrez: '5141'
- word: PDE4
  symbol: PDE4
  source: bioentities_symbol
  hgnc_symbol: PDE4B
  entrez: '5142'
- word: PDE4
  symbol: PDE4
  source: bioentities_symbol
  hgnc_symbol: PDE4C
  entrez: '5143'
- word: PDE4
  symbol: PDE4
  source: bioentities_symbol
  hgnc_symbol: PDE4D
  entrez: '5144'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: GHR
  symbol: GHR
  source: hgnc_symbol
  hgnc_symbol: GHR
  entrez: '2690'
- word: Ghrelin,SUN11031,Anamorelin,Macimorelin
  symbol: ghrelin
  source: hgnc_alias_symbol
  hgnc_symbol: GHRL
  entrez: '51738'
- word: IGF-1
  symbol: IGF1
  source: hgnc_symbol
  hgnc_symbol: IGF1
  entrez: '3479'
- word: IGF-1R
  symbol: IGF1R
  source: hgnc_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
- word: SMAD2/3
  symbol: SMAD2
  source: hgnc_symbol
  hgnc_symbol: SMAD2
  entrez: '4087'
- word: JAK2
  symbol: JAK2
  source: hgnc_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
- word: S6K1
  symbol: S6K1
  source: hgnc_alias_symbol
  hgnc_symbol: RPS6KB1
  entrez: '6198'
- word: MSTN
  symbol: MSTN
  source: hgnc_symbol
  hgnc_symbol: MSTN
  entrez: '2660'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: KLF15
  symbol: KLF15
  source: hgnc_symbol
  hgnc_symbol: KLF15
  entrez: '28999'
- word: MAFBX
  symbol: MAFbx
  source: hgnc_alias_symbol
  hgnc_symbol: FBXO32
  entrez: '114907'
- word: socs3
  symbol: SOCS3
  source: hgnc_symbol
  hgnc_symbol: SOCS3
  entrez: '9021'
- word: SMAD2/3
  symbol: SMAD3
  source: hgnc_symbol
  hgnc_symbol: SMAD3
  entrez: '4088'
chemicals:
- word: SUN11031
  source: MESH
  identifier: C528565
- word: Anamorelin
  source: MESH
  identifier: C000593861
- word: Macimorelin
  source: MESH
  identifier: C582727
- word: Celecoxib
  source: MESH
  identifier: C105934
- word: Fosinopril
  source: MESH
  identifier: D017328
- word: Ruxolitinib
  source: MESH
  identifier: C540383
- word: Mk-0773
  source: MESH
  identifier: C092078
- word: Losartan
  source: MESH
  identifier: D019808
- word: Thalidomide
  source: MESH
  identifier: D013792
- word: MSTN
  source: MESH
  identifier: C525911
- word: BIIB023
  source: MESH
  identifier: C055514
- word: ACE-083
  source: MESH
  identifier: C058288
- word: Ly2495655
  source: MESH
  identifier: C026591
- word: REGN1033
  source: MESH
  identifier: C091523
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
